| [1] |
SU Ya, ZHANG Dongwei, YU Minghui, WANG Chunhua, WU Yueyue.
Observation on the clinical efficacy of compound kushen injection combined with targeted and immune therapy in the treatment of advanced hepatocellular carcinoma
[J]. Tianjin Medical Journal, 2026, 54(3): 324-328.
|
| [2] |
SHEN Zhou, YANG Xiu, CAI Yanfeng.
Clinical study on the treatment of non-alcoholic fatty liver disease with Danggui Shaoyao San combined with Bacillus subtilis dual active bacteria enteric coated capsules
[J]. Tianjin Medical Journal, 2026, 54(2): 196-200.
|
| [3] |
ZHANG Xinglong, HE Hongmei, ZHANG Jing, SHI Ya’nan, REN Lanchun, QIN Xiaohui, SUN Jianghua.
The clinical efficacy of artificial pleural effusion combined with radiofrequency ablation in patients with phrenic top liver cancer
[J]. Tianjin Medical Journal, 2025, 53(8): 856-859.
|
| [4] |
ZHENG Shaoyang, ZHI Hui, WANG Man, WU Bing, ZHANG Qingge, LI Guanyang.
Correlation between levels of sTim-3 and sST2 in peripheral blood and disease severity in patients with alcoholic liver disease
[J]. Tianjin Medical Journal, 2025, 53(4): 383-388.
|
| [5] |
YU Songsong, YIN Jingzhao, WU Tianyu, LI Hao.
Gli gene and protein expression in hepatocellular carcinoma and the relationship with prognosis
[J]. Tianjin Medical Journal, 2025, 53(2): 124-128.
|
| [6] |
WANG Yuanzhen, WEI Hongyan, CHANG Lixian, ZHANG Yingyuan, LIU Chunyun, LIU Li.
Establishment and validation of a risk prediction model for primary liver cancer complicated with pulmonary infection before intervention
[J]. Tianjin Medical Journal, 2024, 52(9): 940-945.
|
| [7] |
WU Jing, FAN Zhijuan, LIU Shuye.
Changes and clinical significance of plasma free amino acid levels in the development of chronic hepatitis B to hepatocellular carcinoma
[J]. Tianjin Medical Journal, 2024, 52(7): 738-742.
|
| [8] |
LIU Xiaoyan, BU Rui, LU Jianfei, DING Yu, ZHANG Xing.
Value of Sonazoid contrast-enhanced ultrasound for preoperatively evaluating pathological grade of hepatocellular carcinoma
[J]. Tianjin Medical Journal, 2024, 52(6): 658-662.
|
| [9] |
MIAO Chunbo, XU Yingchun, CHANG Yifang.
Phlorizin allevistes oxidative stress and apoptosis of rat cardiac myocytes H9C2 induced by hypoxia/reoxygenation by down-regulating miR-125a-5p
[J]. Tianjin Medical Journal, 2024, 52(12): 1233-1238.
|
| [10] |
CAI Dengta, CHANG Jingyi, JIA Shanshan, TU Yinqiong.
Roxadustat improves myocardial ischemia-reperfusion injury in mice by inhibiting apoptosis and inflammatory response
[J]. Tianjin Medical Journal, 2024, 52(11): 1146-1151.
|
| [11] |
ZHANG Jinwu, XIE Dingling, CHEN Li.
The effect of securinine on neurological function recovery after cerebral ischemia-reperfusion injury in rats
[J]. Tianjin Medical Journal, 2023, 51(9): 977-982.
|
| [12] |
MA Yunting, ZHENG Yue, WANG Lujing, SHA Lihui, ZHAO Xinxiang.
Research progress of myocardial strain detection technique in myocardial injury of non-alcoholic fatty liver disease
[J]. Tianjin Medical Journal, 2023, 51(8): 888-891.
|
| [13] |
SHI Jiaxin, LI Nuo, YANG Yegui, FANG Wei, QIN Sina, HUANG Jingju, CHEN Menghua.
Moderately elevating blood potassium concentration can improve mitochondrial function of brain tissue in cardiopulmonary resuscitation rats
[J]. Tianjin Medical Journal, 2023, 51(7): 724-728.
|
| [14] |
LIU Dezhao, LUO Xiaozhi, HUANG Feng.
Mechanism of action of EV-YF1 based on artificially synthesized Y RNA fragments from extracellular vesicles of cardiosphere-derived cells on improving myocardial ischemia-reperfusion injury in mice
[J]. Tianjin Medical Journal, 2023, 51(6): 601-606.
|
| [15] |
WEI Na, LI Siyuan, GAO Yuan, WANG Xuerui, XIAO Bin, NIU Yixuan, YANG Wenxia, LIU Zhenbing.
Protective effect of Shexiang Baoxin Pill on hypoxia-reoxygenation cardiomyocytes and its effect on apoptosis
[J]. Tianjin Medical Journal, 2023, 51(5): 460-463.
|